-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Cap-dependent-endonuclease-IN-16
Category | Influenza Virus |
CAS | 2643370-92-5 |
Description | Cap-dependent endonuclease-IN-16 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-16 is a pyridone polycyclic derivative. Cap-dependent endonuclease-IN-16 has the potential for the research of influenza. |
Product Information
Synonyms | Cap-dependent endonuclease-IN-16|HY-143770|CS-0375151 |
Molecular Weight | 585.58 |
Molecular Formula | C28H25F2N3O7S |
Canonical SMILES | CC1C2=C(C=CC(=C2F)F)C(C3=CC=CC=C3S1)N4C5COCCN5C(=O)C6=C(C(=O)C=CN64)OCOC(=O)OC |
Purity | ≥98% (HPLC) |
Solubility | 10 mM in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
Complexity | 1120 |
Exact Mass | 585.13812764 |
Target | Influenza Virus |
XLogP3-AA | 4.2 |